Abstract:Objective: Inflammatory markers predict cardiovascular events in a wide range of patients. Two factors, fibrinogen (FIB) and high-sensitivity C reactive protein (CRP), are currently entering clinical practice as cardiovascular risk predictors. In patients with type 2 diabetes mellitus, we sought to examine the relationship between macrovascular disease, urinary albumin/creatinine ratio (ACR), and FIB or CRP, as well as the relationship of FIB and CRP with traditional risk predictors of these complications of diabetes. Methods: In 202 consecutive patients with type 2 diabetes mellitus from a diabetes clinic, clinical and biochemical data were obtained and a cross-sectional analysis was performed. Results: Patients with macrovascular disease had higher FIB (P=.02) but not higher CRP. They were older, more likely to have retinopathy or elevated serum creatinine, had higher ACR and lower HDL cholesterol. They were more likely to be treated with statins, beta-blockers, and ASA. Adjustment for statin therapy did not result in significant differences in CRP levels according to macrovascular disease status. Both FIB (P=.01) and CRP (P=.02) were significantly higher in patients with ACR whose values were in the proteinuria range. In multivariate analysis, both FIB (P=.001) and CRP (P=.03) were positively correlated with ACR, but no association was seen between CRP and ACR when FIB was entered in the model. Other factors positively associated with ACR were age, diastolic blood pressure, retinopathy, and hemoglobin A1c (HbA1c). FIB and CRP were strongly correlated (R=.49, P< or =.001) and this effect was independent of statin therapy. CRP was positively associated with body mass index (BMI), serum triglycerides, and sulfonylurea therapy and negatively associated with metformin therapy. Patients on statin therapy had significantly higher FIB and lower CRP. Women on hormone replacement therapy (HRT) had significantly lower FIB and higher CRP. Conclusions: In patients with diabetes: (1) the two markers, FIB and CRP, are interrelated; (2) FIB is significantly associated with presence of microvascular disease, independent of CRP; (3) CRP is strongly associated with metabolic factors but not with complications of diabetes, independently of FIB; (4) statins and HRT were divergently associated with CRP and FIB as HRT was associated with lower FIB and higher CRP, while statins showed the reverse association; and (5) CRP and FIB provide different information about the characteristics and consequences of diabetes mellitus because of divergent associations with biological indicators and therapeutic agents.

C-reactive protein and glycemic control in adults with diabetes

C-reactive Protein for Predicting Cardiovascular and All-Cause Mortality in Type 2 Diabetic Patients: A Meta-Analysis

Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus

Relationship between hs-CRP and HbA1c in Diabetes Mellitus Patients: 2015–2017 Korean National Health and Nutrition Examination Survey

Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control

The Relationship Between C-reactive Protein and Glycemic Control in Short Duration Diabetic Patients

Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes

Contribution of High Sensible Crp (Hscrp) in the Assessment of the Risk of Onset of Type 2 Diabetes and its Cardiovascular Complications

C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome

Impact of C-reactive Protein on Long-Term Mortality in Acute Myocardial Infarction Patients with Diabetes and Those Without.

A Linear Positive Association Between High-Sensitivity C-reactive Protein and the Prevalence of Cardiovascular Disease among Individuals with Diabetes

Association of Serum Levels of Glycated Albumin, C-reactive Protein and Tumor Necrosis Factor-Α with the Severity of Coronary Artery Disease and Renal Impairment in Patients with Type 2 Diabetes Mellitus

Gingival crevicular fluid levels of interleukin-1beta and glycemic control in patients with chronic periodontitis and type 2 diabetes

Glycated Hemoglobin Level is Significantly Associated with the Severity of Coronary Artery Disease in Non-Diabetic Adults

Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population.

Hemoglobin Glycation Index Is Associated With Cardiovascular Diseases in People With Impaired Glucose Metabolism

[Study on the Associations Between Inflammatory Factor and Insulin Resistance As Well As Type 2 Diabetes with Macrovascular Complications].

High Sensitivity C‐reactive Protein and Prediabetes Progression and Regression in Middle‐aged and Older Adults: A Prospective Cohort Study

Association Between High-Sensitivity C-Reactive Protein and Diabetic Kidney Disease in Patients With Type 2 Diabetes Mellitus

Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: the Bogalusa Heart Study

Role of C-Reactive Protein in Diabetic Inflammation